期刊文献+

^(153)钐-乙二胺四甲基膦酸联合伊班磷酸钠缓解骨转移性癌疼痛

^(153)Sm-EDTMP and ibandronate monosodium used for cancer patients to alleviate multiple bone metastasis pain
下载PDF
导出
摘要 目的153钐-乙二胺四甲基膦酸(153Sm-EDTMP)联合伊班磷酸钠控制多发性骨转移癌疼痛,探讨其疼痛缓解率。方法106例多发性骨转移癌患者用153Sm-EDTMP联合伊班磷酸钠治疗,观察骨痛缓解及生活质量提高情况。结果严重():CR23例,PR16例,MR3例,NR3例。中度()CR18例,PR15例,MR3例,NR2例。轻度(+):CR14例,PR7例,NR2例。止痛有效率87.7%,生活质量明显提高,无严重毒副反应。结论153Sm-EDTMP联合伊班磷酸钠治疗多发性骨转移安全有效。 Aim To investigate the effect of 153 Sm-EDTMP and iban-dronate monosodium in alleviating multiple bone metastas is pain of the p a-tients with cancer.Methods 153 Sm-EDTMP combined with ibandronate monosodium treatment was performed to ob serve the remission of bone pain and the improvement of quality of life(QOL)in 106patients with cancer,60males and 46females with an average a ge of 55years(aged 29-67),in-cluding 36cases of mammary cancer,22cases of lung cancer,5cases of pancreatic cancer,9cases of gastric carcinoma,7c ases of hepatocarcin o-ma,12cases of large intestine cancer,11cases of pr ostate carcinoma and4cases of lymphoma.Results Severe cases included 23of CR ,16of PR,3of MR and 3of NR;moderate cases inclu ded 18of CR,15of PR ,3of MR and 2of NR;mild cases included 14of CR,7of PR and 2of NR.The e ffective rate of pain relieving was87.7%(93/106),and quality of li fe was significantly improved.No fatal to xic effects occurred.Conclusion 153 Sm-EDTMP combined with ibandronate mon osodium treatment for cancer multi- ple bone metastasis is effective and reliable.
出处 《中国临床康复》 CAS CSCD 2003年第20期2849-2850,共2页 Chinese Journal of Clinical Rehabilitation
关键词 ^153钐-乙二胺四甲基膦酸 伊班磷酸钠 骨转移性癌 疼痛 联合治疗 毒副反应 bone neoplasms /secondary samarium ethyleredi-amines organophosphorus compounds
  • 相关文献

参考文献8

  • 1Hou EC. The combined therapy for cancer pain. Zhongguo Linchuang Kangfu( Chin J Clin Rehabil)2002; 8(16): 2419.
  • 2Mcewan AJ. Use of radionuclides for the palliation of bone metastases. Semin Radiat Oncol 2000; 10:103 - 114.
  • 3Serafini AN. Systemic metabolic radiotherapy with samarium-153 EDTMP for the treatment of painful bone metastasis. Q J Nucl Med 2001;45:91 -99.
  • 4Cameron PJ, Klemp PF, Martindale AA, Turner JH. Prospective ^153Sm-EDTMP therapy dosimetry by whole-body scintigraphy. Nucl Med Commun 1999: 20:609 -615.
  • 5Serafini AN. Samarium Sm-153 lexidronam for the palliation of bone pain associated with metastases. Cancer 2000; 88:2934 - 2939.
  • 6Boissier S, Ferreras M, Peyruchaud O, et al. Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases. Cancer Res 2000; 60:2949 - 2954.
  • 7Bauss F, Lalla S, Endele R, Hothorn LA. Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged rats. J Rheumatol 2002; 29:2200 - 2208.
  • 8Smith SY, Recker BB, Hannan M, Muller B, Bauss F. Intermittent intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomolgus monkeys. Bone 2003, 32:45 - 55.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部